2-Apr-2026 7:30 AM CST - Business Wire Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 7, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2026 financial results and respond to questions from financial analysts. Investors and the public may access the live webcast and corresponding slides by visiting the Zoetis website at https://investor.zoetis.com/events-pr
24-Mar-2026 7:43 AM CST - Yahoo Finance Is Zoetis (ZTS) Now At An Attractive Price After Its 28% One Year Slide Wondering if Zoetis at around US$115.67 is a bargain or a value trap? This article focuses squarely on what the current price might represent for you as an investor. The stock has seen a 2.1% decline over the past week,
16-Mar-2026 8:50 PM CST - Yahoo Finance Zoetis Cuts Guidance As Librela Safety Questions Test Growth Story Zoetis (NYSE:ZTS) reduced its full year guidance after raising safety concerns around its osteoarthritis drug Librela. Management said it intends to address questions on Librela with science based evidence on safety and efficacy.
15-Mar-2026 9:14 PM CST - Yahoo Finance Is Zoetis Inc. (ZTS) A Good Stock To Buy Now? Is ZTS a good stock to buy now? We came across a bullish thesis on Zoetis Inc. on Rebound Capital's Substack. In this article, we will summarize the bulls' thesis on ZTS. Zoetis Inc.'s share was trading at $131.
13-Mar-2026 12:47 PM CST - Yahoo Finance Zoetis (ZTS) Loses 8.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner The heavy selling pressure might have exhausted for Zoetis (ZTS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
13-Mar-2026 11:51 AM CST - Seeking Alpha Zoetis: The King Of Animal Health On Sale Zoetis Inc. (ZTS) is a wide-moat animal health leader, rated BUY due to strong fundamentals and undervaluation despite industry-leading profitability. Zoetis trades at a forward P/E of 17.28x, below both S&P 500 and weaker rival Elanco, with a target price ...
12-Mar-2026 7:30 AM CST - Business Wire Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 10:30 a.m. ET. Interested parties can access the live audio webcast of the presentation by visiting https://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoetis is the worl
5-Mar-2026 7:35 PM CST - Seeking Alpha Zoetis: Good Potential To Re-Rate Higher Over 3 To 5 Years Nomura Value Fund discusses its new position in Zoetis Inc. after selling Kenvue during Q4 2025. Read the full analysis for more details.
5-Mar-2026 7:30 AM CST - Business Wire Zoetis to Participate in Upcoming Investor Conferences $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Wetteny Joseph, Executive Vice President and Chief Financial Officer, will participate in fireside chats at the following investor conferences. Leerink Global Healthcare Conference on Monday, March 9, 2026 at 3:00 p.m. ET Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 9:30 a.m. ET Interested parties can access live audio webcasts of the presentations by visiting https://investor.zoeti
Latest ZTS Trades by Congress Members
13-MAR-2026 - Gilbert Cisneros, CA (District 31) sold some (partial sale) valued between $1,001 and $15,000.
2-Apr-2026 7:30 AM CST - Business Wire Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 7, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2026 financial results and respond to questions from financial analysts. Investors and the public may access the live webcast and corresponding slides by visiting the Zoetis website at https://investor.zoetis.com/events-pr
24-Mar-2026 7:43 AM CST - Yahoo Finance Is Zoetis (ZTS) Now At An Attractive Price After Its 28% One Year Slide Wondering if Zoetis at around US$115.67 is a bargain or a value trap? This article focuses squarely on what the current price might represent for you as an investor. The stock has seen a 2.1% decline over the past week,
16-Mar-2026 8:50 PM CST - Yahoo Finance Zoetis Cuts Guidance As Librela Safety Questions Test Growth Story Zoetis (NYSE:ZTS) reduced its full year guidance after raising safety concerns around its osteoarthritis drug Librela. Management said it intends to address questions on Librela with science based evidence on safety and efficacy.
15-Mar-2026 9:14 PM CST - Yahoo Finance Is Zoetis Inc. (ZTS) A Good Stock To Buy Now? Is ZTS a good stock to buy now? We came across a bullish thesis on Zoetis Inc. on Rebound Capital's Substack. In this article, we will summarize the bulls' thesis on ZTS. Zoetis Inc.'s share was trading at $131.
13-Mar-2026 12:47 PM CST - Yahoo Finance Zoetis (ZTS) Loses 8.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner The heavy selling pressure might have exhausted for Zoetis (ZTS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
13-Mar-2026 11:51 AM CST - Seeking Alpha Zoetis: The King Of Animal Health On Sale Zoetis Inc. (ZTS) is a wide-moat animal health leader, rated BUY due to strong fundamentals and undervaluation despite industry-leading profitability. Zoetis trades at a forward P/E of 17.28x, below both S&P 500 and weaker rival Elanco, with a target price ...
12-Mar-2026 7:30 AM CST - Business Wire Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 10:30 a.m. ET. Interested parties can access the live audio webcast of the presentation by visiting https://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoetis is the worl
5-Mar-2026 7:35 PM CST - Seeking Alpha Zoetis: Good Potential To Re-Rate Higher Over 3 To 5 Years Nomura Value Fund discusses its new position in Zoetis Inc. after selling Kenvue during Q4 2025. Read the full analysis for more details.
5-Mar-2026 7:30 AM CST - Business Wire Zoetis to Participate in Upcoming Investor Conferences $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Wetteny Joseph, Executive Vice President and Chief Financial Officer, will participate in fireside chats at the following investor conferences. Leerink Global Healthcare Conference on Monday, March 9, 2026 at 3:00 p.m. ET Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 9:30 a.m. ET Interested parties can access live audio webcasts of the presentations by visiting https://investor.zoeti
